1-[[3-Methoxy-4-[[1-[8-[4-[[2-methoxy-4-[[4-(2-methoxyphenyl)piperazin-1-yl]methyl]phenoxy]methyl]triazol-1-yl]octyl]triazol-4-yl]methoxy]phenyl]methyl]-4-(2-methoxyphenyl)piperazine

InChIKey	`ZMVCPWQWTYDCHV-UHFFFAOYSA-N`
Compound Name	1-[[3-Methoxy-4-[[1-[8-[4-[[2-methoxy-4-[[4-(2-methoxyphenyl)piperazin-1-yl]methyl]phenoxy]methyl]triazol-1-yl]octyl]triazol-4-yl]methoxy]phenyl]methyl]-4-(2-methoxyphenyl)piperazine
Canonical SMILES	`COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCn2cc(COc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Homologous
Avg pChEMBL	7.83
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P21917	DRD4	Homo sapiens	Human	PF00001	8.3	Ki	ChEMBL
P14416	DRD2	Homo sapiens	Human	PF00001	7.7	Ki	ChEMBL;BindingDB
P35462	DRD3	Homo sapiens	Human	PF00001	7.5	Ki	ChEMBL;BindingDB